A disclosure form filed for his nomination revealed that the outspoken vaccine critic pulled in roughly $10 million over the last year related to dividends from his vaccine lawsuits, anti-vax ...
The last few years have been marked by many big pharma companies opting to move away from diversification and towards more focused operations. Ben Hargreaves explores what is driving this ...